Not applicableStudy completedNCT03688698What this trial is testingPET/MRI in PAH PatientsWho this might be right forPulmonary Arterial Hypertension Medical University of Bialystok 37
Not applicableStudy completedNCT00946114What this trial is testingTo Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 WeeksWho this might be right forPulmonary Hypertension Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 32
Early research (Phase 1)Study completedNCT04041648What this trial is testingSingle Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606Who this might be right forPulmonary Arterial Hypertension Pharmosa Biopharm Inc. 52
Large-scale testing (Phase 3)Study completedNCT00718952What this trial is testingThe Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial HypertensionWho this might be right forPulmonary Hypertension Tongji University 60
Early research (Phase 1)WithdrawnNCT01251835What this trial is testingEffect Of Rifampin On Pharmacokinetics Of SitaxsentanWho this might be right forPulmonary Arterial Hypertension Pfizer
Early research (Phase 1)Study completedNCT04908397What this trial is testingCarnitine Consumption and Augmentation in Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial HypertensionFamilial Primary Pulmonary HypertensionPrimary Pulmonary Hypertension+2 more Vanderbilt University Medical Center 10
Not applicableStudy completedNCT01557582What this trial is testingAssessmet of Patients With PAH Right Ventricular VolumeWho this might be right forPulmonary Arterial Hypertension VentriPoint Diagnostics Ltd. 103
Not applicableLooking for participantsNCT06528418What this trial is testingIdentification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled BreathWho this might be right forLung CancerLung InfectionCOPD+13 more ChromX Health 10,000
Large-scale testing (Phase 3)Study completedNCT03187678What this trial is testingSafety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Actelion 20
Testing effectiveness (Phase 2)WithdrawnNCT01352026What this trial is testingEvaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)Who this might be right forPulmonary Arterial Hypertension Nantes University Hospital
Not applicableLooking for participantsNCT06917196What this trial is testingPROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.Who this might be right forPulmonary Arterial Hypertension (PAH)Lung Fibrosis Interstitial Fondazione IRCCS Policlinico San Matteo di Pavia 16
Post-approval studies (Phase 4)Ended earlyNCT00458042What this trial is testingTransitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment SatisfactionWho this might be right forHypertension, Pulmonary United Therapeutics 10
Not applicableUnknownNCT02558582What this trial is testingEffect of Exercise Training in Patients With Pulmonary HypertensionWho this might be right forHypertension, Pulmonary University of Zurich 32
Not applicableNot Yet RecruitingNCT07804524What this trial is testingAssessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAHWho this might be right forPulmonary Arterial Hypertension (PAH)Pulmonary Vascular DiseaseHigh Altitude+3 more Silvia Ulrich Somaini 20
Not applicableStudy completedNCT01847352What this trial is testingIron Status and Hypoxic Pulmonary Vascular ResponsesWho this might be right forLung HypoxiaPulmonary Arterial HypertensionIron Deficiency University of Oxford 31
Early research (Phase 1)Study completedNCT02267655What this trial is testing3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPFWho this might be right forPulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis Bellerophon 8
Not applicableStudy completedNCT02763735What this trial is testingRight Ventricular Metabolism in Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial HypertensionHealthy Vanderbilt University Medical Center 34
Not applicableEnded earlyNCT02525926What this trial is testingPulmonary Artery Denervation for Treatment of Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Centre Hospitalier Universitaire de Nice 1
Testing effectiveness (Phase 2)Looking for participantsNCT06992440What this trial is testingEmpagliflozin to Improve Right Ventricular Function in Pulmonary Arterial HypertensionWho this might be right forPulmonary Arterial Hypertension Gustavo A Heresi, MD, MS 78
Large-scale testing (Phase 3)Study completedNCT04896008What this trial is testingSotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)Who this might be right forPulmonary Arterial Hypertension Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 173